John A. Boockvar - JoVE Visualize

Showing results (101-110 of 108) with videos related to

Pageof 11

Sort By:

You have reached the last page of results.This site can display upto 108 results.

Journal of Neurosurgery|May 3, 2014

Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastasesA Gabriella Wernicke, Menachem Z Yondorf, Luke Peng, et al.

Cancer Journal (Sudbury, Mass.)|September 4, 2003

Neural stem cell biology may be well suited for improving brain tumor therapiesStephen Yip, Karen S Aboody, Michael Burns, et al.

Journal of Neurosurgery|October 23, 2010

Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical articleJohn A Boockvar, Apostolos J Tsiouris, Christoph P Hofstetter, et al.

Operative Neurosurgery (Hagerstown, Md.)|March 20, 2018

Neuroradiological and Neuropathological Changes After 177Lu-Octreotate Peptide Receptor Radionuclide Therapy of Refractory EsthesioneuroblastomaJulia R Schneider, Deborah R Shatzkes, Stephen C Scharf, et al.

Journal of Neuro-Oncology|July 30, 2024

Comparative efficacy and safety of sodium fluorescein-guided surgery versus standard white light for resection of brain metastases: a systematic review and meta-analysisMarcio Yuri Ferreira, Maria Antônia O M Pereira, Matheus Hemais, et al.

Cancers|February 11, 2023

Childhood Brain Tumors: A Review of Strategies to Translate CNS Drug Delivery to Clinical TrialsRuman Rahman, Miroslaw Janowski, Clare L Killick-Cole, et al.

Future Oncology (London, England)|December 7, 2023

Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patientsIan Y Lee, Simon Hanft, Michael Schulder, et al.

Oncotarget|April 19, 2013

A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma CareRichard E Kast, John A Boockvar, Ansgar Brüning, et al.

Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:

Pageof 11

You have reached the last page of results.This site can display upto 108 results.

Journal of Neurosurgery|May 3, 2014

Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastasesA Gabriella Wernicke, Menachem Z Yondorf, Luke Peng, et al.

Cancer Journal (Sudbury, Mass.)|September 4, 2003

Neural stem cell biology may be well suited for improving brain tumor therapiesStephen Yip, Karen S Aboody, Michael Burns, et al.

Journal of Neurosurgery|October 23, 2010

Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical articleJohn A Boockvar, Apostolos J Tsiouris, Christoph P Hofstetter, et al.

Operative Neurosurgery (Hagerstown, Md.)|March 20, 2018

Neuroradiological and Neuropathological Changes After 177Lu-Octreotate Peptide Receptor Radionuclide Therapy of Refractory EsthesioneuroblastomaJulia R Schneider, Deborah R Shatzkes, Stephen C Scharf, et al.

Journal of Neuro-Oncology|July 30, 2024

Comparative efficacy and safety of sodium fluorescein-guided surgery versus standard white light for resection of brain metastases: a systematic review and meta-analysisMarcio Yuri Ferreira, Maria Antônia O M Pereira, Matheus Hemais, et al.

Cancers|February 11, 2023

Childhood Brain Tumors: A Review of Strategies to Translate CNS Drug Delivery to Clinical TrialsRuman Rahman, Miroslaw Janowski, Clare L Killick-Cole, et al.

Future Oncology (London, England)|December 7, 2023

Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patientsIan Y Lee, Simon Hanft, Michael Schulder, et al.

Oncotarget|April 19, 2013

A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma CareRichard E Kast, John A Boockvar, Ansgar Brüning, et al.

Pageof 11